LobbyingSolis Mammography lobbying by quarter
Solis Mammography's latest lobbying report covers Q4 2025, at $20K. The four quarters Q4 2025–Q3 2026 total $20K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Solis Mammography
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $20K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $20K | 1 |
| Q1 2023 | $20K | 1 |
| Q2 2023 | $20K | 1 |
| Q3 2023 | $20K | 1 |
| Q4 2023 | $20K | 1 |
| Q1 2024 | $20K | 1 |
| Q2 2024 | $20K | 1 |
| Q3 2024 | $20K | 1 |
| Q4 2024 | $20K | 1 |
| Q1 2025 | $20K | 1 |
| Q2 2025 | $20K | 1 |
| Q3 2025 | $20K | 1 |
| Q4 2025 | $20K | 1 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$260K · 13 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES13 reports
- SENATE13 reports
Firms it paid
| Firm | ||
|---|---|---|
| Holland & Knight | $260K | 13 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 01/11for Q4 2025 | Holland & Knight | $20K |
| 25/10/11for Q3 2025 | Holland & Knight | $20K |
| 25/07/06for Q2 2025 | Holland & Knight | $20K |
| 25/04/11for Q1 2025 | Holland & Knight | $20K |
| 25/01/11for Q4 2024 | Holland & Knight | $20K |
| 24/10/02for Q3 2024 | Holland & Knight | $20K |
| 24/07/06for Q2 2024 | Holland & Knight | $20K |
| 24/04/11for Q1 2024 | Holland & Knight | $20K |
| 24/01/06for Q4 2023 | Holland & Knight | $20K |
| 24/01/06for Q4 2023 | Holland & Knight | $20K |
| 23/10/08for Q3 2023 | Holland & Knight | $20K |
| 23/07/09for Q2 2023 | Holland & Knight | $20K |
| 23/04/07for Q1 2023 | Holland & Knight | $20K |
| 23/01/14for Q4 2022 | Holland & Knight | $20K |